1) HBV/HEV fusion Antigen
HBV/HEV融合抗原
1.
Denaturation,Renaturation and Purification of Inclusion Bodies of HBV/HEV fusion Antigen Expressed In E.coli;
HBV/HEV融合抗原大肠杆菌表达包涵体的变复性和纯化
2) HBV/HEV bivalent vaccinal antigen
HBV/HEV二价疫苗性抗原基因
1.
Preliminary study on optimization of expression condition of vector expressing HBV/HEV bivalent vaccinal antigen in E.coli;
HBV/HEV二价疫苗性抗原基因在E.coli中表达条件优化的初步研究
4) fusion antigen
融合抗原
1.
Objective To express and purify Mycobacterium tuberculosis 38kDa(phosphate transport system protein 1,PstS1)-U1(urine protein 1)fusion antigen and determine its immunological activity.
用纯化的融合抗原免疫家兔获得抗血清,用该血清以及活动性肺结核患者血清对纯化产物的抗原活性进行测定。
2.
The aim was to develop a single multiple-epitope fusion antigen which incorporates all of the major immunodominant epitopes from the six functional regions of the HCV genome.
结论 :所构建融合抗原可可溶性表达 ,可以用作双抗原夹心ELISA的酶标抗原 ,所含生物素标签也可用作酶联检测的生物素—亲和素信号放大系统。
3.
A plasmid(DNA vaccine)pSC-IL12,coexpressing hepatitis B virus(HBV)envelope-core fusion antigen and murine IL-12,was constructed.
为增加ＨＢＶＤＮＡ疫苗的抗原表位谱 ,我们构建了一系列ＨＢＶ表面 -核心融合抗原ＤＮＡ疫苗进行小鼠免疫试验。
5) chimeric antigen
融合抗原
1.
Objective:To investigate the immunogenicity and characte ri stics of immune response of the chimeric antigen PfCP 2.
目的 :探讨恶性疟原虫融合抗原 Pf CP- 2 。
6) Anti-HEV
抗-HEV
1.
Anti-HEV Prevalence Situation Investigation about Young Adults Crowd in Jincheng;
晋城市区青壮年人群抗-HEV流行状况调查
补充资料：HEV
分子式：
CAS号：
性质：可引起肠道型非甲非乙型肝炎(ET-NANBH)。系一直径27～34nm，无包膜的球形病毒，含正链RNA分子，长约7.5kb。
CAS号：
性质：可引起肠道型非甲非乙型肝炎(ET-NANBH)。系一直径27～34nm，无包膜的球形病毒，含正链RNA分子，长约7.5kb。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条